Skip to main
DOX

Amdocs (DOX) Stock Forecast & Price Target

Amdocs (DOX) Analyst Ratings

Based on 3 analyst ratings
Strong Buy
Strong Buy 67%
Buy 33%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Amdocs is a financially strong and reputable company with a stable revenue stream from its widespread presence in North America and other regions. Its use of AI and cloud technology allows for continuous growth and adds value to its services, though the recent acquisition presents integration risks. These factors, combined with its strong customer relationships, make Amdocs a promising investment for those seeking long-term growth opportunities in the communication services sector.

Bears say

Amdocs is facing challenges in diversifying its customer base beyond its two biggest clients, AT&T and T-Mobile, who account for a significant portion of its revenue. Despite its strong position in the industry and its offerings such as GenAI and managed services, competition from other BSS/OSS and CRM providers, as well as large vendors like Oracle and Salesforce, poses a threat. Additionally, Amdocs' transition to AI is still in early stages, and the decreasing spending appetite of its largest customers could have a significant impact on its business. Furthermore, the company's declining gross margin and lowered guidance for F2Q26 and FY26 suggest potential headwinds in the near future.

Amdocs (DOX) has been analyzed by 3 analysts, with a consensus rating of Strong Buy. 67% of analysts recommend a Strong Buy, 33% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Amdocs and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Amdocs (DOX) Forecast

Analysts have given Amdocs (DOX) a Strong Buy based on their latest research and market trends.

According to 3 analysts, Amdocs (DOX) has a Strong Buy consensus rating as of Jul 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $86.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $86.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Amdocs (DOX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.